Predictors of associated autoimmune diseases in families with type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium
- 25 February 2011
- journal article
- research article
- Published by Wiley in Diabetes/Metabolism Research and Reviews
- Vol. 27 (5) , 493-498
Abstract
Background: Type 1 diabetes (T1D) is a clinically heterogeneous disease. The presence of associated autoimmune diseases (AAIDs) may represent a distinct form of autoimmune diabetes, with involvement of specific mechanisms. The aim of this study was to find predictors of AAIDs in the Type 1 Diabetes Genetics Consortium data set.Methods: Three thousand two hundred and sixty‐three families with at least two siblings with T1D were included. Clinical information was obtained using questionnaires, anti‐GAD (glutamic acid decarboxylase) and anti‐protein tyrosine phosphatase (IA‐2) were measured and human leukocyte antigen (HLA) genotyping was performed. Siblings with T1D with and without AAIDs were compared and a multivariate regression analysis was performed to find predictors of AAIDs. T1D‐associated HLA haplotypes were defined as the four most susceptible and protective, respectively.Results: One or more AAIDs were present in 14.4% of the T1D affected siblings. Age of diabetes onset, current age and time since diagnosis were higher, there was a female predominance and more family history of AAIDs in the group with AAIDs, as well as more frequent anti‐GAD and less frequent anti‐IA‐2 antibodies. Risk and protective HLA haplotype distributions were similar, though DRB1*0301‐DQA1*0501‐DQB1*0201 was more frequent in the group with AAIDs. In the multivariate analysis, female gender, age of onset, family history of AAID, time since diagnosis and anti‐GAD positivity were significantly associated with AAIDs.Conclusions: In patients with T1D, the presence of AAIDs is associated with female predominance, more frequent family history of AAIDs, later onset of T1D and more anti‐GAD antibodies, despite longer duration of the disease. The predominance of certain HLA haplotypes suggests that specific mechanisms of disease may be involved. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 28 references indexed in Scilit:
- Measurement of islet cell antibodies in the Type 1 Diabetes Genetics Consortium: efforts to harmonize procedures among the laboratoriesClinical Trials, 2010
- Quality control of phenotypic forms data in the Type 1 Diabetes Genetics ConsortiumClinical Trials, 2010
- Factors for thyroid autoimmunity in children and adolescents with type 1 diabetes mellitusUpsala Journal of Medical Sciences, 2009
- Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus - data from a German/Austrian multicentre surveyPediatric Diabetes, 2008
- Defining the Role of the MHC in Autoimmunity: A Review and Pooled AnalysisPLOS Genetics, 2008
- High Titer of Autoantibodies to GAD Identifies a Specific Phenotype of Adult-Onset Autoimmune DiabetesDiabetes Care, 2007
- The Type 1 Diabetes Genetics ConsortiumAnnals of the New York Academy of Sciences, 2006
- Analysis of HLA genes in families with autoimmune diabetes and thyroiditisHuman Immunology, 2004
- Humoral beta‐cell autoimmunity in relation to HLA‐defined disease susceptibility in preclinical and clinical type 1 diabetesAmerican Journal of Medical Genetics, 2002
- Combined Analysis of GAD65 and ICA512(IA-2) Autoantibodies in Organ and Non-organ-specific Autoimmune Diseases Confers High Specificity for Insulin-dependent Diabetes MellitusJournal of Autoimmunity, 1998